A review of Science Lessons: What the Business of Biotech Taught Me About management by Gordon Binder and Philip Bashe (Harvard Business School Press, 304 pages, $29.95).
October 01, 2007 - WILLIAM PATRICK - Business - Business Strategy
Getting Down to Business Osiris has shifted its focus from research to developing products. A stem cell therapy for bones is already on the market and a therapy for treating transplant complications could be next.
September 01, 2007 - By Mark Ratner - Business - Business Strategy
Spot's Little Helper Canines need drugs, too. The trick is getting pharma to pay attention.
September 01, 2007 - By Varese Layzer - Business - Business Strategy
A Hardware Store for the 21st Century Invitrogen has prospered by providing kits and reagents to make life easier at the lab. Supplying the needs of stem cell researchers is the next frontier.
September 01, 2007 - By William Patrick - Business - Business Strategy
Debating Evolution PriceWaterhouseCoopers sees the global pharmaceutical market doubling to $1.3 trillion by 2020, but says industry will have to change to capitalize on opportunities.
June 14, 2007 - DANIEL S. LEVINE - Business - Business Strategy
Hatching Companies Pfizer gets first tenant for its incubator as it hopes to tap new ideas from outside to help fill the evolving void from drugs going off patent.
July 20, 2007 - DANIEL S. LEVINE - Health - Drug Delivery